Zahedi Kamyar, Wang Zhaohui, Barone Sharon, Prada Anne E, Kelly Caitlin N, Casero Robert A, Yokota Naoko, Porter Carl W, Rabb Hamid, Soleimani Manoocher
Division of Nephrology and Hypertension, Department of Pediatrics, Children's Hospital Medical Center, Cincinnati, Ohio 45267, USA.
Am J Physiol Renal Physiol. 2003 May;284(5):F1046-55. doi: 10.1152/ajprenal.00318.2002. Epub 2003 Jan 28.
Ischemia-reperfusion injury (IRI) is the major cause of acute renal failure in native and allograft kidneys. Identifying the molecules and pathways involved in the pathophysiology of renal IRI will yield valuable new diagnostic and therapeutic information. To identify differentially regulated genes in renal IRI, RNA from rat kidneys subjected to an established renal IRI protocol (bilateral occlusion of renal pedicles for 30 min followed by reperfusion) and time-matched kidneys from sham-operated animals was subjected to suppression subtractive hybridization. The level of spermidine/spermine N(1)-acetyltransferase (SSAT) mRNA, an essential enzyme for the catabolism of polyamines, increased in renal IRI. SSAT expression was found throughout normal kidney tubules, as detected by nephron segment RT-PCR. Northern blots demonstrated that the mRNA levels of SSAT are increased by greater than threefold in the renal cortex and by fivefold in the renal medulla at 12 h and returned to baseline at 48 h after ischemia. The increase in SSAT mRNA was paralleled by an increase in SSAT protein levels as determined by Western blot analysis. The concentration of putrescine in the kidney increased by approximately 4- and approximately 7.5-fold at 12 and 24 h of reperfusion, respectively, consistent with increased functional activity of SSAT. To assess the specificity of SSAT for tubular injury, a model of acute renal failure from Na(+) depletion (without tubular injury) was studied; SSAT mRNA levels remained unchanged in rats subjected to Na(+) depletion. To distinguish SSAT increases from the effects of tubular injury vs. uremic toxins, SSAT was increased in cis-platinum-treated animals before the onset of renal failure. The expression of SSAT mRNA and protein increased by approximately 3.5- and >10-fold, respectively, in renal tubule epithelial cells subjected to ATP depletion and metabolic poisoning (an in vitro model of kidney IRI). Our results suggest that SSAT is likely a new marker of tubular cell injury that distinguishes acute prerenal from intrarenal failure.
缺血再灌注损伤(IRI)是自体肾和移植肾急性肾衰竭的主要原因。识别参与肾IRI病理生理学过程的分子和途径将产生有价值的新诊断和治疗信息。为了识别肾IRI中差异调节的基因,将经历既定肾IRI方案(双侧肾蒂阻断30分钟后再灌注)的大鼠肾脏以及假手术动物的时间匹配肾脏的RNA进行抑制性消减杂交。多胺分解代谢的关键酶亚精胺/精胺N(1)-乙酰基转移酶(SSAT)mRNA水平在肾IRI中升高。通过肾单位节段RT-PCR检测发现,SSAT表达存在于整个正常肾小管中。Northern印迹显示,缺血后12小时,肾皮质中SSAT的mRNA水平增加了三倍以上,肾髓质中增加了五倍,48小时后恢复到基线水平。Western印迹分析确定,SSAT mRNA的增加与SSAT蛋白水平的增加平行。再灌注12小时和24小时时,肾脏中腐胺浓度分别增加了约4倍和约7.5倍,这与SSAT功能活性增加一致。为了评估SSAT对肾小管损伤的特异性,研究了由钠缺乏引起的急性肾衰竭模型(无肾小管损伤);钠缺乏的大鼠中SSAT mRNA水平保持不变。为了区分SSAT增加是由肾小管损伤还是尿毒症毒素的影响所致,顺铂处理的动物在肾衰竭发作前SSAT增加。在经历ATP耗竭和代谢中毒的肾小管上皮细胞(肾IRI的体外模型)中,SSAT mRNA和蛋白的表达分别增加了约3.5倍和>10倍。我们的结果表明,SSAT可能是区分急性肾前性肾衰竭和肾性肾衰竭的肾小管细胞损伤的新标志物。